UK markets open in 2 hours 48 minutes
NIKKEI 225
38,991.50 +374.40 (+0.97%) HANG SENG
18,924.68 -270.92 (-1.41%) CRUDE OIL
77.12 -0.45 (-0.58%) GOLD FUTURES
2,374.70 -18.20 (-0.76%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,545.94 -320.51 (-0.58%)
REGENERON PHARMAC.DL-,001 (RGO.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:01AM CEST
| Previous close | 902.20 |
| Open | 911.40 |
| Bid | 908.40 x 0 |
| Ask | 910.40 x 0 |
| Day's range | 911.40 - 911.40 |
| 52-week range | 911.40 - 911.40 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
Key Insights Regeneron Pharmaceuticals' estimated fair value is US$1,903 based on 2 Stage Free Cash Flow to Equity...
- Zacks
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Sanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with inadequately controlled CRSwNP, if approved by the FDA.
- Simply Wall St.
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
Key Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have significant...
© 2024 Yahoo. All rights reserved.